Schedule 13G ownership disclosure

CLEVELAND BIOLABS INC

Security class unavailable · CUSIP: 185860202

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
93,365
Percent of class
0.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-18-000008
Form type
SC 13G/A
Filer
Statera Biopharma, Inc.
CIK
CIK 1318641
Filed
Jan 04, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub